openPR Logo
Press release

Toxoid Vaccine Market Size & Forecast 2024-2031 | Immunization Demand Drives Growth | Major Companies - GlaxoSmithKline Plc, Merck & Co. Inc., Serum Institute of India Pvt. Ltd., Sanofi S.A., CSL Seqirus, Dexa Group, Dano Vaccines

06-09-2025 02:35 PM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Toxoid Vaccine Market

Toxoid Vaccine Market

Global Toxoid Vaccine Market is expected to reach at a significant CAGR during the forecast period 2024-2031.

Toxoid Vaccine Market is comprehensively covered in the DataM Intelligence report, which offers critical data, industry trends, and market intelligence. The study delves into the competitive environment, assessing leading players on their product portfolios, pricing, financial health, strategic growth initiatives, and geographic expansion.

Unlock exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/toxoid-vaccine-market?ca

Toxoid vaccines are developed from inactivated toxic compounds produced by bacteria, making them safe while still triggering an immune response. They are primarily used to prevent diseases such as tetanus and diphtheria. By targeting the toxins rather than the bacteria itself, toxoid vaccines help the immune system recognize and neutralize these harmful substances in future exposures.

Major players in the Toxoid Vaccine market

The prominent players in Toxoid Vaccine market research report are: GlaxoSmithKline Plc, Merck & Co. Inc., Serum Institute of India Pvt. Ltd., Sanofi S.A., CSL Seqirus, Dexa Group, Dano Vaccines, Bharat Biotech International Ltd., Abbott Laboratories, and Panacea Biotech

The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.

Toxoid Vaccine Market Key Development

→ In September 2022, Serum Institute of India submitted phase 2-3 clinical trial data to the DCGI panel for its Tdap vaccine targeting diphtheria, pertussis, and tetanus.

→ On October 10, 2022, GSK's BOOSTRIX vaccine received FDA approval for use during the third trimester of pregnancy to protect infants under two months from pertussis.

→ In June 2022, the National Health Mission replaced the TT vaccine with DTaP in the Universal Immunization Program to counter declining diphtheria immunity in people over 60.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/toxoid-vaccine-market?ca

Toxoid Vaccine Market Segments

By Disease Type: Tetanus, Diphtheria, Pertussis, Botulism

By Vaccine Type: Diphtheria, Tetanus, and Pertussis (DtaP), Diphtheria and Tetanus (DT), Tetanus, Diphtheria, and Pertussis (Tdap), Monovalent Tetanus Toxoid (TT), Tetanus and Diphtheria (Td), Others

By Age Group: Neonates, Children, Adults, Others

By End-User: Hospitals and Clinics, Government Organizations, Others

The Toxoid Vaccine industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.

Regions Covered:

The global Toxoid Vaccine Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Toxoid Vaccine Market Size & Forecast 2024-2031 | Immunization Demand Drives Growth | Major Companies - GlaxoSmithKline Plc, Merck & Co. Inc., Serum Institute of India Pvt. Ltd., Sanofi S.A., CSL Seqirus, Dexa Group, Dano Vaccines here

News-ID: 4057582 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

United States Solar Panel Market is to reach US$ 642.3 million by 2031- Driven By Rising Renewable Energy Adoption and Declining PV Costs | DataM Intelligence
United States Solar Panel Market is to reach US$ 642.3 million by 2031- Driven B …
Leander, Texas and TOKYO, Japan- U.S. Solar Panel Market reached US$ 165.2 million in 2022 and is expected to reach US$ 642.3 million by 2031 growing with a CAGR of 18.5% during the forecast period 2024-2031. The market is driven by government incentives like tax credits, growing environmental awareness, and decreasing solar panel costs. Rising investments and renewable energy targets also boost demand. Download Free sample report:- https://www.datamintelligence.com/download-sample/solar-panel-market?pratik Industry Latest News 2025: ✅
United States AI in Elderly Care Market is to reach US$ 208.59 billion by 2032- Driven by creating strong demand for technologies | DataM Intelligence
United States AI in Elderly Care Market is to reach US$ 208.59 billion by 2032- …
Leander, Texas and TOKYO, Japan- U.S. AI in Elderly Care Market reached US$ 34.42 billion in 2024 and is expected to reach US$ 208.59 billion by 2032, growing with a CAGR of 25.26% during the forecast period 2025-2032. The market is driven by the aging population is expanding rapidly, creating strong demand for technologies that improve caregiving efficiency, support remote health monitoring, and address workforce shortages in senior care. Download Free
U.S. oxo alcohol market is to reach around USD 4.52 billion by 2034-Driven by rising plasticizer demand, expanding construction activity, strong industrial manufacturing needs | DataM Intelligence
U.S. oxo alcohol market is to reach around USD 4.52 billion by 2034-Driven by ri …
U.S. oxo alcohol market size was approximately USD 3.08 billion in 2025 and is projected to reach around USD 4.52 billion by 2034, with a compound annual growth rate (CAGR) of about 4.35% from 2025 to 2034. The market is driven by rising plasticizer demand, expanding construction activity, strong industrial manufacturing needs, increasing use in coatings and cleaners, and improved production efficiency driving stable consumption. Download Free sample report:- https://www.datamintelligence.com/download-sample/oxo-alcohol-market?pratik
Japanese vegan supplement market is to reach USD 1.22 billion by 2030 - Fueled by Rising Health Awareness and Innovation in Plant-Based Formulations | DataM Intelligence 2025
Japanese vegan supplement market is to reach USD 1.22 billion by 2030 - Fueled b …
Tokyo-japan - The Japan vegan supplement market generated USD 577.9 million revenue in 2023, projected to reach USD 1.22 billion by 2030 at 11.3% CAGR. The market is driven by rising plant-based lifestyles, increasing health awareness, lactose intolerance concerns, demand for clean-label nutrition, and expanding product innovation across vitamins, proteins, and functional blends. Download Free sample report:- https://www.datamintelligence.com/download-sample/vegan-supplements-market?pratik Industry Latest News 2025: ✅ FANCL Corporation launched a new line of plant-based

All 5 Releases


More Releases for Toxoid

Global Tetanus Toxoid Vaccine Market Impact of AI and Automation
Tetanus Toxoid Vaccine Market Impact of AI and Automation The global Tetanus Toxoid Vaccine market was valued at approximately USD 1.2 billion in 2022 and is projected to reach around USD 1.5 billion by 2028. This growth corresponds to a compound annual growth rate (CAGR) of approximately 4.5% during the forecast period. Factors contributing to this growth include increasing awareness about vaccination, rising incidence of tetanus in underdeveloped regions, and government
Toxoid Vaccine Market Size, Share 2024, Impressive Industry Growth Report 2031
The global toxoid vaccine market is expected to grow at a significant CAGR during the forecast period (2024-2031). The key companies across the globe are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launch, and product innovation to remain competitive in the marketplace. For instance, in March 2020, In December 2019, Panacea Biotec, received an award worth $24.3
Tetanus Toxoid Vaccine Market Growth & Regional Trends 2024
"The Business Research Company recently released a comprehensive report on the Global Tetanus Toxoid Vaccine Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive
Unveiling Insights: Global Diphtheria Toxoid Market Analysis 2023-2031
𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧: Welcome to our comprehensive analysis of the Global Diphtheria Toxoid Market, covering a broad spectrum of factors shaping its growth trajectory from 2023 to 2031. Amidst the backdrop of the COVID-19 pandemic, the market dynamics have witnessed significant shifts, influencing the demand-supply equilibrium and strategic decisions across various segments. In this blog, we delve into the market size, share, and the impact of COVID-19, alongside a detailed examination of resin
Toxoid Vaccine Market Trends, Research Report, Growth, Opportunities, Forecast 2 …
Toxoid vaccine market is biologically inactivated forms of native toxins. The market for toxoid vaccine is projected to be growing at a CAGR of 4.3% for the forecast. The most commonly used toxoid is tetanus toxoid, diphtheria-derived toxoids and other proteins are used occasionally. Diphtheria toxoid is produced globally in a standard fashion, in the US, production and testing procedures are specified in the Code of Federal Regulations. Diphtheria toxoid
Toxoid Vaccines Market Outlook, Supportive Judgments | DTP, Polio, MMR
Report Ocean recently published a new report on the Global Toxoid Vaccines Market. The study has an in-depth analysis of the forecast period from 2021-2025. The report reveals a comprehensive picture of the Toxoid Vaccines Market situation, taking into consideration all major trends, market dynamics, and competitive factors. Additionally, the report contains key statistics concerning the Toxoid Vaccines Market situation of the leading key players, key market trends, and potential